Experience from a single centre concerning the surgical spectrum and outcome of adolescents and adults with congenitally malformed hearts in West Africa

Edwin, Frank; Sereboe, Lawrence; Tettey, Mark; Aniteye, Ernest; Kotei, D.; Tamatey, Martin; Entsua-Mensah, Kow; Frimpong-Boateng, K.

doi:10.1017/s1047951109990679

Cited by 23 publications

(26 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The late presentation of CHD presents special challenges, which is unique to the developing country situation, and the need for a structured management pathway 76 77. It is also apparent from countries with long-established cardiac surgical programmes that increased survival in childhood will lead to an increasing number of patients with grown-up CHD 78.…”

Section: Innovations Advances and Locally-appropriate Management In mentioning

confidence: 99%

Congenital heart disease and rheumatic heart disease in Africa: recent advances and current priorities

Zühlke

Mirabel

Marijon

2013

Heart

148

141

View full text Add to dashboard Cite

Africa has one of the highest prevalence of heart diseases in children and young adults, including congenital heart disease (CHD) and rheumatic heart disease (RHD). We present here an extensive review of recent data from the African continent highlighting key studies and information regarding progress in CHD and RHD since 2005. Main findings include evidence that the CHD burden is underestimated mainly due to the poor outcome of African children with CHD. The interest in primary prevention for RHD has been recently re-emphasised, and new data are available regarding echocardiographic screening for subclinical RHD and initiation of secondary prevention. There is an urgent need for comprehensive service frameworks to improve access and level of care and services for patients, educational programmes to reinforce the importance of prevention and early diagnosis and a relevant research agenda focusing on the African context.

show abstract

Section: Innovations Advances and Locally-appropriate Management In mentioning

confidence: 99%

Congenital heart disease and rheumatic heart disease in Africa: recent advances and current priorities

Zühlke

Mirabel

Marijon

2013

Heart

148

141

View full text Add to dashboard Cite

show abstract

“…By this time, they were severely limited in functional capacities and their congenital heart lesions too advanced to obtain a maximum benefit from the intervention. Some of the reasons for the delay in establishing a diagnosis or seeking necessary treatment may be due to the lack of available regional facilities or the patient's inability to access the facilities for economic reasons [10]. One of the patients in particular, for reasons unknown, failed to seek the required treatment for a prolonged period.…”

Section: Discussionmentioning

confidence: 99%

Pattern of Adult Congenital Heart Disease in a Tertiary Care Hospital in Saudi Arabia

Galal¹

2017

J Healthc Commun

View full text Add to dashboard Cite

show abstract

“…For example, in West Africa there are no pediatric cardiac surgery centers, and in Ghana only 20 percent of children diagnosed with congenital heart disease could afford surgery within one year of echocardiographic diagnosis. [75] In Brazil, the mean waiting time for coronary artery bypass graft surgery was 23 months with a 6% annual mortality rate on the waiting list; for heart valve surgery, the wait time was reported at 32 months with a 13% annual mortality. [76] Surgical missions funded by international charities cannot meet the overwhelming demand in LMICs for those with surgical CVD, and are also not sustainable long-term solutions.…”

Section: Access To Imaging and Clinical Services In Low- And Middle-imentioning

confidence: 99%

Bioimaging and Subclinical Cardiovascular Disease in Low- and Middle-Income Countries

Vedanthan

Choi

Baber

et al. 2014

J. of Cardiovasc. Trans. Res.

View full text Add to dashboard Cite

Cardiovascular disease (CVD) is the leading cause of mortality worldwide and also exerts a significant economic burden, especially in low- and middle-income countries (LMICs). Detection of subclinical CVD, before an individual experiences a major event, may therefore offer the potential to prevent or delay morbidity and mortality, if combined with an appropriate care response. In this review, we discuss imaging technologies that can be used to detect subclinical atherosclerotic CVD (carotid ultrasound, coronary artery calcification) and non-atherosclerotic CVD (echocardiography). We review these imaging modalities, including aspects such as rationale, relevance, feasibility, utilization, and access in LMICs. The potential gains in detecting subclinical CVD may be substantial in LMICs, if earlier detection leads to earlier engagement with the health care system to prevent or delay cardiac events, morbidity, and premature mortality. Thus, dedicated studies examining the feasibility, utility, and cost-effectiveness of detecting subclinical CVD in LMICs are warranted.

show abstract

Experience from a single centre concerning the surgical spectrum and outcome of adolescents and adults with congenitally malformed hearts in West Africa

Abstract: The study demonstrates the feasibility of surgery for adolescents and adults with congenitally malformed hearts in the sub-region with a good outcome. Majority (77.8%) of patients present with less complex lesions.

Cited by 23 publications

References 13 publications

Congenital heart disease and rheumatic heart disease in Africa: recent advances and current priorities

Congenital heart disease and rheumatic heart disease in Africa: recent advances and current priorities

Pattern of Adult Congenital Heart Disease in a Tertiary Care Hospital in Saudi Arabia

Bioimaging and Subclinical Cardiovascular Disease in Low- and Middle-Income Countries

Contact Info

Product

Resources

About